Skip to content
FreshSource

Zimbabwe Declines ‘One-Sided’ US Healthcare Assistance Deal Over Data Concerns

Health funding illustration
The offered American funding was aimed at initiatives for treating and preventing HIV/Aids, TB, and malarial diseases.

Zimbabwe has declined a major US health deal valued at 367 million US dollars (£272m) over five years due to Washington's request for sensitive information.

This move was revealed following a internal memorandum from December was disclosed, revealing that Head of State Emmerson Mnangagwa deemed the arrangement was "skewed".

A government representative later explained that the United States was seeking biological samples for scientific study and commercial purposes while refused to share the benefits from future medical innovations.

"We are forced to start the difficult and regrettable process of winding down our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.

The US Embassy said the United States had provided over $1.9bn for health programmes to Zimbabwe over the last two decades.

A doctors' association in Zimbabwe has urged continued dialogue to find a agreement acceptable to all parties so the nation's vital HIV programme can be sustained.

Wider Implications

This rejection follows a similar situation in Kenya, where a court blocked a related deal with the US following legal challenges were raised about the security of Kenyans' health data.

After resuming the presidency last year, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).

USAID had overseen aid for the American government, but Trump claimed its spending was "wasteful" and his government was pursuing direct bilateral deals to boost openness and responsibility.

Based on statements, 16 nations in Africa have so far agreed to these new agreements, constituting over $18.3bn in new funding.

Details of the Declined Deal

The funds for Zimbabwe would have gone towards "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.

"It is our view this cooperation would have delivered significant advantages for Zimbabwean communities, particularly the 1.2 million currently receiving antiretroviral therapy through American-funded programmes," Tremont added.

However, government spokesperson Nick Mangwana said the arrangement was "unfair".

"The proposal required Zimbabwe to provide its genetic material and health information over an extended period, with no corresponding promise of benefiting from any medical innovations – such as new medicines or tests – that might result from that provided information," his statement read.

"Effectively, our country would supply the raw materials for medical research with no certainty that the end products would be available to our citizens if a future pandemic arise."

Sovereignty and Global Health

Mangwana further said that the American exit from the global health body and its pursuit of bilateral health agreements were upending frameworks already set up via the global health agency.

The spokesperson cited its Pathogen Access and Benefit Sharing system designed to deal with future pandemics.

"This framework is designed to ensure that when a nation contributes its information, the resulting advantages – such as medicines and cures – are shared equitably, not monopolised solely by those with the resources to create them."

Zimbabwe's reservations regarding the US deal "are not meant as hostility towards the US," Mangwana stressed.

"We welcome further dialogue with our American counterparts on how future co-operation might be arranged in a way that honours the sovereignty and interests of both nations."

Medical Community Response

A leading public health body said it understood the government's concerns, but urged that talks need to persist given that a large portion of the nation's HIV programmes depended on foreign aid.

"If technical issues exist, including those relating to information security or agreement terms, these can frequently be resolved through technical clarification and negotiated safeguards," the group commented.

This impasse highlights the continuing debate between accepting vital international aid and protecting a country's data in an increasingly interconnected world.

The writer

Chad Paul

Maya is a tech journalist and startup advisor with over a decade of experience covering Silicon Valley innovations and global digital trends.

FreshSource

Type to search articles.